CBRAIN.CO
Price:
$170.6
Market Cap:
$3.34B
cBrain A/S, a software company, develops and provides software solutions for government, private, education, and non-profit sectors in Denmark and internationally. The company offers F2 Digital Platform, an integrated software solution that combines case management, process management, and knowledge management, including full support for specialized government routines and compliance. It also provides F2 platform for automation of the public administration; and Government Climate Software. The company was founded in 2002 and is headquartered in Copenhagen, Denmark.[Read more]
Industry
Software - Application
IPO Date
2006-02-22
Stock Exchange
CPH
Ticker
CBRAIN.CO
According to cBrain A/S’s latest financial reports and current stock price. The company's current ROE is 29.82%. This represents a change of 296.24% compared to the average of 7.53% of the last 4 quarters.
The mean historical ROE of cBrain A/S over the last ten years is 15.49%. The current 29.82% ROE has changed 92.50% with respect to the historical average. Over the past ten years (40 quarters), CBRAIN.CO's ROE was at its highest in in the June 2023 quarter at 17.96%. The ROE was at its lowest in in the March 2018 quarter at -0.67%.
Average
15.49%
Median
15.87%
Minimum
2.92%
Maximum
27.57%
Discovering the peaks and valleys of cBrain A/S ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 201.93%
Maximum Annual ROE = 27.57%
Minimum Annual Increase = -62.76%
Minimum Annual ROE = 2.92%
Year | ROE | Change |
---|---|---|
2023 | 27.57% | 21.74% |
2022 | 22.64% | -1.50% |
2021 | 22.99% | 56.73% |
2020 | 14.67% | 66.18% |
2019 | 8.83% | 201.93% |
2018 | 2.92% | -62.76% |
2017 | 7.85% | -25.22% |
2016 | 10.50% | -47.25% |
2015 | 19.90% | 16.60% |
2014 | 17.06% | 36.45% |
The current ROE of cBrain A/S (CBRAIN.CO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
24.40%
5-year avg
19.34%
10-year avg
15.49%
cBrain A/S’s ROE is less than ChemoMetec A/S (25.62%), less than Ambu A/S (8.12%), less than Genmab A/S (17.44%), greater than Zealand Pharma A/S (-18.21%), less than Netcompany Group A/S (11.05%),
Company | ROE | Market cap |
---|---|---|
25.62% | $6.75B | |
8.12% | $33.92B | |
17.44% | $96.40B | |
-18.21% | $58.67B | |
11.05% | $15.58B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like cBrain A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like cBrain A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is cBrain A/S's ROE?
How is the ROE calculated for cBrain A/S (CBRAIN.CO)?
What is the highest ROE for cBrain A/S (CBRAIN.CO)?
What is the 3-year average ROE for cBrain A/S (CBRAIN.CO)?
What is the 5-year average ROE for cBrain A/S (CBRAIN.CO)?
How does the current ROE for cBrain A/S (CBRAIN.CO) compare to its historical average?